Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Abbott Laboratories
Engages in the discovery, development, manufacture and sale of health care products

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products.

It operates through four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

The Established Pharmaceutical Products segment includes branded generic pharmaceuticals manufactured, marketed and sold outside the United States and are generally sold directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its owned distribution centers and public warehouses, depending on the market served.

The Diagnostic Products segment covers diagnostic systems and tests manufactured, marketed, and sold worldwide to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate-care testing sites, and plasma protein therapeutic companies.

The segment's products are generally marketed and sold directly from Abbott-owned distribution centers, public warehouses and third-party distributors.

The Nutritional Products segment includes pediatric and adult nutritional products manufactured, marketed, and sold worldwide.

Its products are generally marketed and sold directly to customers and to institutions, wholesalers, retailers, health care facilities, government agencies, and third-party distributors from owned distribution centers or third-party distributors.

The Vascular Products segment includes coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease manufactured, marketed and sold worldwide.

The segment's products are generally marketed and sold directly to hospitals from Abbott-owned distribution centers and public warehouses.

The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Managers
NameAgeSinceTitle
Miles White611999Chairman & Chief Executive Officer
Brian B. Yoor-1997Chief Financial Officer & Senior VP-Finance
Roxanne Schuh Austin, CPA552000Independent Director
Jim Farrell732006Independent Director
Samuel C. Scott III, MBA702007Independent Director
Glenn Fletcher Tilton672007Independent Director
William A. Osborn, MBA682008Lead Independent Director
Robert J. Alpern, MD652008Independent Director
Edward Michael Liddy, MBA702010Independent Director
Phebe Novakovic582010Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,706,957,661 1,464,534,295 85.8% 234,648,138 13.7% 85.8%
Shareholders
NameEquities%
The Vanguard Group, Inc. 100,243,961 6.82%
BlackRock Fund Advisors 62,494,331 4.25%
SSgA Funds Management, Inc. 50,136,730 3.41%
Massachusetts Financial Services Co. 36,390,381 2.48%
T. Rowe Price Associates, Inc. 32,791,216 2.23%
Northern Trust Investments, Inc. 22,494,731 1.53%
Delaware Management Business Trust 17,598,140 1.20%
Wellington Management Co. LLP 16,635,427 1.13%
PRIMECAP Management Co. 15,720,699 1.07%
State Farm Investment Management Corp. 15,428,373 1.05%
Holdings
NameEquities%Valuation
Mylan NV (MYL) 69,750,00013.0%2,545,875,000 USD
Abbott India Limited (ABBOTINDIA) 10,719,09750.4%804,279,359 USD
DOMESCO Medical Import Export JS Corp (DMC) 17,950,60851.7%60,229,316 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ABBOTT LABORATORIES-20.70%55 801
JOHNSON & JOHNSON9.00%304 591
PFIZER INC.-2.01%191 942
ROCHE HOLDING LTD.-19.61%188 878
NOVARTIS AG-19.07%178 737
MERCK & CO., INC.15.85%168 544
SANOFI-4.20%103 510
BRISTOL-MYERS SQUIBB C..-17.95%93 522
GLAXOSMITHKLINE PLC6.85%91 041
BAYER AG-25.06%76 831
ELI LILLY AND CO-20.34%74 748
ALLERGAN PLC-39.30%71 149
NOVO NORDISK A/S-41.01%68 352
ASTRAZENECA PLC-11.62%64 588
ABBOTT LABORATORIES-15.23%55 801
SHIRE PLC-3.05%52 210
TAKEDA PHARMACEUTICAL ..-22.03%32 564
ASTELLAS PHARMA INC-9.55%29 477
MYLAN NV-33.44%19 258
EISAI CO., LTD-16.80%17 197
SHIONOGI & CO LTD-2.08%16 452
Sector Pharmaceuticals - NEC
Abbott Laboratories : Connections
100 road Abbott Park
US-IL 60064-6400 Palatine, Illinois
États-Unis (les)

Phone : +1 (224) 667 6100
Fax : +1
Internet : http://www.abbott.com
Markets and indexes
- NYSE
- Main Market
- SP100 / SP500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  US0028241000
- Bloomberg Code :  ABT:US
- Reuters Code :  ABT.N
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem